These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19534587)

  • 21. Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study.
    Härtter S; Ursing C; Morita S; Tybring G; von Bahr C; Christensen M; Röjdmark S; Bertilsson L
    Clin Pharmacol Ther; 2001 Jul; 70(1):10-6. PubMed ID: 11452239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
    Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
    Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four-week treatment with omeprazole increases the metabolism of caffeine.
    Nousbaum JB; Berthou F; Carlhant D; Riche C; Robaszkiewicz M; Gouerou H
    Am J Gastroenterol; 1994 Mar; 89(3):371-5. PubMed ID: 8122647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patients.
    Raaska K; Raitasuo V; Laitila J; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2004 Jan; 94(1):13-8. PubMed ID: 14725610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.
    Sinués B; Sáenz MA; Lanuza J; Bernal ML; Fanlo A; Juste JL; Mayayo E
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):159-66. PubMed ID: 10067814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two novel methods for the determination of CYP1A2 activity using the paraxanthine/caffeine ratio.
    Doude van Troostwijk LJ; Koopmans RP; Guchelaar HJ
    Fundam Clin Pharmacol; 2003 Jun; 17(3):355-62. PubMed ID: 12803575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of propafenone on the pharmacokinetics of caffeine in humans.
    Michaud V; Mouksassi MS; Labbé L; Bélanger PM; Ferron LA; Gilbert M; Grech-Bélanger O; Turgeon J
    Ther Drug Monit; 2006 Dec; 28(6):779-83. PubMed ID: 17164694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats.
    Noh K; Seo YM; Lee SK; Bista SR; Kang MJ; Jahng Y; Kim E; Kang W; Jeong TC
    Arch Pharm Res; 2011 Jan; 34(1):119-25. PubMed ID: 21468923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male Chinese volunteers.
    Chen Y; Liu WH; Chen BL; Fan L; Han Y; Wang G; Hu DL; Tan ZR; Zhou G; Cao S; Zhou HH
    Ann Pharmacother; 2010 Jun; 44(6):1038-45. PubMed ID: 20484172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of Qingkailing injection on rat CYP1A2 and CYP2D6 activity].
    Liu Y; Wang J; Bao YY; Yu WJ; Zhu DL
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2044-7. PubMed ID: 18161301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers.
    Peng WX; Li HD; Zhou HH
    Eur J Clin Pharmacol; 2003 Jul; 59(3):237-41. PubMed ID: 12756512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects.
    Asimus S; Elsherbiny D; Hai TN; Jansson B; Huong NV; Petzold MG; Simonsson US; Ashton M
    Fundam Clin Pharmacol; 2007 Jun; 21(3):307-16. PubMed ID: 17521300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of caffeine intake 12 or 24 hours prior to melatonin intake and CYP1A2*1F polymorphism on CYP1A2 phenotyping by melatonin.
    Härtter S; Korhonen T; Lundgren S; Rane A; Tolonen A; Turpeinen M; Laine K
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):300-4. PubMed ID: 17040215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of long-term ethanol consumption on CYP1A2 activity.
    Rizzo N; Hispard E; Dolbeault S; Dally S; Leverge R; Girre C
    Clin Pharmacol Ther; 1997 Nov; 62(5):505-9. PubMed ID: 9390106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in-vivo effects of sho-saiko-to, a traditional Chinese herbal medicine, on two cytochrome P450 enzymes (1A2 and 3A) and xanthine oxidase in man.
    Saruwatari J; Nakagawa K; Shindo J; Nachi S; Echizen H; Ishizaki T
    J Pharm Pharmacol; 2003 Nov; 55(11):1553-9. PubMed ID: 14713367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects.
    Thai C; Tayo B; Critchley D
    Clin Pharmacol Drug Dev; 2021 Nov; 10(11):1279-1289. PubMed ID: 33951339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a reversed-phase HPLC method for CYP1A2 phenotyping by use of a caffeine metabolite ratio in saliva.
    Begas E; Kouvaras E; Tsakalof AK; Bounitsi M; Asprodini EK
    Biomed Chromatogr; 2015 Nov; 29(11):1657-63. PubMed ID: 25891161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ephedra water decoction and cough tablets containing ephedra and liquorice on CYP1A2 and the pharmacokinetics of theophylline in rats.
    Tang J; Zhou X; Ji H; Zhu D; Wu L
    Phytother Res; 2012 Mar; 26(3):470-4. PubMed ID: 21796703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous assessment of CYP3A4 and CYP1A2 activity in vivo with alprazolam and caffeine.
    Schmider J; Brockmöller J; Arold G; Bauer S; Roots I
    Pharmacogenetics; 1999 Dec; 9(6):725-34. PubMed ID: 10634135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2.
    Labedzki A; Buters J; Jabrane W; Fuhr U
    Biochem Pharmacol; 2002 Jun; 63(12):2159-67. PubMed ID: 12110375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.